3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
32
Leukemia, Lymphocytic, Chronic, B-Cell
22
Myelodysplastic Syndromes
9
Lymphoma, Follicular
8
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Recurrence
5
Leukemia, Myelomonocytic, Chronic
5
Multiple Myeloma
4
Chromosome 17 deletion
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myeloid
3
Hematologic Neoplasms
3
Waldenstrom Macroglobulinemia
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Breast Neoplasms
2
Tumor Lysis Syndrome
1
Small Cell Lung Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Myeloid Malignancy
1
Myeloid Malignancies
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
venetoclax
×
Clear all
No trials found.